Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04929184 · ClinicalTrials.gov registry record · NA

Speech Processing in Stuttering

A NA study of Stuttering and Stuttering, Adult, sponsored by University of Michigan.

Completed
Registry status
NA
Development phase
143
Enrollment target
2
Study locations

NCT04929184 is a NA study of Stuttering and Stuttering, Adult that has completed, run by University of Michigan. The registered enrollment target is 143 participants, below the 752-participant average among 6 other Stuttering trials with a reported enrollment target (81% lower). The trial reports 2 study locations across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04929184, a NA study of Stuttering and Stuttering, Adult, has completed, sponsored by University of Michigan.

COMPLETED
Registry status
NA
Development phase
143 participants
Enrollment target
2
Study locations

Study Summary

This research is being done to better understand stuttering, specifically how people who stutter may process and/or produce speech. Eligible participants enrolled will complete a variety of computer and speech-based tasks on up to 2 visits.

Interventions

  • BEHAVIORAL Speech and non-speech tasks

Study Locations (2)

Michigan

  • University of Michigan - Ann Arbor
  • Michigan State University - East Lansing

Trial Details

FieldValue
Enrollment Target 143 participants
Start Date 2022-04-04
Est. Completion 2025-06-16
Phase NA

Sponsor

University of Michigan

1,327 total trials

What the Registry Record Tells You About NCT04929184

The ClinicalTrials.gov registry entry for NCT04929184 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 143 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 752-participant average among 6 other Stuttering trials with a reported enrollment target (81% lower). The listed sponsor is University of Michigan, which has 1,327 total studies on file at ClinicalTrials.gov.

The record links to 3 conditions, with Stuttering appearing as the primary indexed condition, and to 1 intervention - of which Speech and non-speech tasks is the first listed.

NCT04929184 reports 2 study locations spanning 1 distinct geographic area - top geographies include Michigan.

Frequently Asked Questions

What is clinical trial NCT04929184 about?

NCT04929184 is a clinical study titled "Speech Processing in Stuttering". This research is being done to better understand stuttering, specifically how people who stutter may process and/or produce speech. Eligible participants enrolled will complete a variety of computer and speech-based tasks on up to 2 visits.

What is the current status of trial NCT04929184?

This trial is currently completed. It is a NA study. The enrollment target is 143 participants. The study started on 2022-04-04. Estimated completion is 2025-06-16.

What conditions does trial NCT04929184 study?

This clinical trial studies the following conditions: Stuttering, Stuttering, Adult, Stuttering, Childhood.

What interventions are being tested in trial NCT04929184?

The interventions under investigation include: Speech and non-speech tasks (BEHAVIORAL).

Who is sponsoring clinical trial NCT04929184?

This trial is sponsored by University of Michigan, which has 1,327 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT04929184 being conducted?

This trial has 2 study locations across Michigan. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Stuttering

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.